National Comprehensive Cancer Network



About NCCN

Chronic Myelogenous Leukemia Panel - Disclosures as of 5/17/2011

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Date Completed

Camille N. Abboud, MD

None

Bristol-Myers Squibb Company;
Genzyme Corporation;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation

None

None

None

2/11/2015

Mojtaba Akhtari, MD

None

None

None

None

None

5/15/2013

Jessica Altman, MD

None

Celgene Corporation;
Epicept

None

None

None

2/17/2015

Ellin Berman, MD

None

None

None

None

None

5/23/2014

Daniel J. DeAngelo, MD, PhD

None

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation;
Sigma-Tau Pharmaceuticals, Inc.

None

None

None

1/27/2015

Steven Devine, MD

Genzyme Corporation

Novartis Pharmaceuticals Corporation

None

None

None

5/22/2014

Amir T. Fathi, MD

None

None

None

None

None

1/20/2015

Lauren Gallagher, RPh, PhD

None

None

None

None

None

12/8/2014

Jason Gotlib, MD, MS

None

Novartis Pharmaceuticals Corporation

None

None

None

3/21/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

9/16/2014

Madan Jagasia, MD

None

None

None

None

None

6/5/2014

Joan S. McClure, MS

None

None

None

None

None

12/8/2014

Joseph O. Moore, MD

ARIAD Pharmaceuticals, Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

Amgen Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

None

None

None

2/15/2015

Susan O'Brien, MD

None

None

None

None

None

8/27/2013

Javier Pinilla-Ibarz, MD, PhD

None

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation;
Innovive

None

None

None

9/3/2013

Jerald P. Radich, MD

None

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

None

None

None

5/30/2014

Vishnu VB. Reddy, MD

None

None

None

None

None

2/10/2015

Neil P. Shah, MD, PhD

None

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company

None

None

None

2/10/2015

Paul J. Shami, MD

None

Genzyme Corporation;
Novartis Pharmaceuticals Corporation

None

None

None

1/28/2013

B. Douglas Smith, MD

None

Bristol-Myers Squibb Company;
Celgene Corporation;
Novartis Pharmaceuticals Corporation

None

None

None

2/11/2015

David S. Snyder, MD

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation

Bristol-Myers Squibb Company;
Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation

None

None

None

2/10/2015

Hema Sundar, PhD

None

None

None

None

None

2/18/2015

Meir Wetzler, MD

None

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation;
Chemgenix

None

None

None

7/30/2014